Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men and women of any race or ethnicity
- People who are not obese (body mass index of 30 or below)
- People who have been diagnosed with type 1 diabetes
- People whose body is no longer producing insulin on its own (confirmed by a "C-peptide negative" test result — confirm with trial site if unsure what this means)
Who may not be able to join:
- Women who are currently pregnant
- People who currently smoke cigarettes
- People who are taking steroid medications to reduce inflammation (such as prednisone)
- People who are taking medications that affect the body's adrenaline-related responses (such as beta-blockers or certain breathing inhalers)
- People whose blood cell levels are too low (a blood measurement called hematocrit below 33%)
- People who have HIV or hepatitis
- People who have heart disease or problems with blood flow in their limbs
- People who have nerve damage, eye damage related to diabetes, or kidney damage related to diabetes
- People who have any other illness or condition that a study doctor believes could affect the results or make participation unsafe (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 513-558-4437
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Glucagon; Hepatic glucose production; Glucose infusion rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.